Brief: Graphite Bio Reports Third Quarter 2022 Financial Results

LENZ Therapeutics

09/11/2022 21:57

Nov 9 (Reuters) - Graphite Bio Inc  GRPH.O :
    * GRAPHITE BIO REPORTS RECENT BUSINESS PROGRESS AND THIRD
QUARTER
2022 FINANCIAL RESULTS
    * GRAPHITE BIO INC - $305.1 MILLION IN CASH, CASH
EQUIVALENTS AND
INVESTMENTS IN MARKETABLE SECURITIES AS OF SEPTEMBER 30, 2022
    * GRAPHITE BIO INC - CASH RUNWAY INTO Q4 2024
    * GRAPHITE BIO INC - QTRLY LOSS PER SHARE $0.45

Source text for Eikon:  ID:nBw9CwLhPa 
Further company coverage:  GRPH.O 
 ((Reuters.Briefs@thomsonreuters.com;))